Anthony Lau
On June 20, 2025, the Board appointed Mr. Anthony Lau as a member of the Board, effective immediately, to fill one of the resulting vacancies.
Highest-materiality recent filing
iSpecimen prices $2.5M private placement at $5.12/share; regains Nasdaq minimum bid price compliance
Private placement of 488,281 shares and pre-funded warrants for gross proceeds of ~$2.5M at $5.12 per share (or $5.1199 for warrants).
iSpecimen effectuates 1-for-40 reverse stock split to regain Nasdaq compliance
Reverse stock split effective 4:30 p.m. ET on April 27, 2026; trading on split-adjusted basis began April 28.
iSpecimen raises $5.5M via Series C Convertible Preferred Stock at $800/share
Issued 6,875 shares of Series C Convertible Non-Voting Preferred at $800/share for $5.5M aggregate.
iSpecimen receives Nasdaq deficiency notice for bid price below $1.00; cure deadline May 18, 2026
Notice received Nov 19, 2025; stock continues trading under ISPC with no immediate delisting.
Reverse stock split approved at ratio from 1:10 to 1:100; Board to set exact ratio.
iSpecimen plans $200M Solana-based digital asset treasury, hires BlockArrow
iSpecimen to build up to $200M corporate treasury reserve on Solana blockchain ecosystem.
iSpecimen raises $1.75M in private placement of common stock and pre-funded warrants
Gross proceeds ~$1.75M from 1,559,828 shares (or pre-funded warrants) at $1.122/share; closed August 4, 2025.
iSpecimen closes $4M public offering of common stock and pre-funded warrants
Sold 5,714,283 securities (1,482,644 shares + 4,231,639 pre-funded warrants) at $0.70/share for gross $4M.
Received Nasdaq letter on June 4, 2025 regarding non-compliance with Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.
On June 20, 2025, the Board appointed Mr. Anthony Lau as a member of the Board, effective immediately, to fill one of the resulting vacancies.
On June 18, 2025, Richard J. Paolone and John L. Brooks III each resigned from the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”), effective immediately.
On June 18, 2025, Richard J. Paolone and John L. Brooks III each resigned from the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”), effective immediately.
Max materiality 0.75 · Median 0.55 · Most common event other_material